Latest News
European Commission clears first pertuzumab biosimilar in Europe
29 April 2026 - China-based biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) and US healthcare company Organon (NYSE:OGN) announced on Wednesday that the European Commission has approved POHERDY (pertuzumab), the first biosimilar to P...
Circio partners with USC to advance non-viral RNA delivery technologies
29 April 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) said on Wednesday that it has entered into a research collaboration with Universidad de Santiago de Compostela through its TraffikGene project to explore non-viral delivery of circul...
Cirius Therapeutics introduces gestational diabetes initiative
29 April 2026 - Clinical-stage pharmaceutical company Cirius Therapeutics Incannounced on Tuesday a planning grant from the Gates Foundation to advance the development of CIR-0602K as a potential postpartum therapeutic for women with a history of ges...
Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence
29 April 2026 - US biopharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) announced on Tuesday the publication of an original research article titled 'Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis' in the ...
Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study
29 April 2026 - Insilico Medicine (HKEX:3696), a China-based, clinical-stage, generative AI-driven drug discovery company, announced on Tuesday that the inhalation solution of Rentosertib (ISM001-055), the company's first-in-class drug candidate...